Oculis Holding AG (CR5) Stock Price & News

All values in CHF	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	243.00K	411.00K	209.00K	310.00K
Cost of goods sold	14.12M	13.29M	14.05M	15.28M
Cost of revenue	14.12M	13.29M	14.05M	15.28M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.42M	7.76M	7.89M	8.60M
Operating expense	6.42M	7.76M	7.89M	8.60M
Total operating expenses	20.54M	21.04M	21.94M	23.88M
Operating income	-20.30M	-20.63M	-21.73M	-23.57M
Other non operating income	3.09M	-3.24M	-7.98M	12.10M
EBT including unusual items	-16.84M	-23.70M	-28.95M	-9.96M
EBT excluding unusual items	-16.84M	-23.70M	-28.95M	-9.96M
Income tax expense	13.00K	-182.00K	-98.00K	6.00K
Effective tax rate	-0.08%	0.77%	0.34%	-0.06%
Other operating expenses	-	-	-	-
Net income	-16.86M	-23.51M	-28.85M	-9.97M
Net profit margin	-6,936.21%	-5,721.17%	-13,804.78%	-3,216.13%
Earnings per share	-0.32	-0.42	-0.49	-0.16
Interest and investment income	438.00K	319.00K	367.00K	592.00K
Interest expense	-162.00K	-241.00K	-173.00K	-309.00K
Net interest expenses	276.00K	78.00K	194.00K	283.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-20.14M	-20.60M	-21.57M	-23.39M
Gain or loss from assets sale	-	-	-	-

Finance